Current:Home > FinanceMissouri House backs legal shield for weedkiller maker facing thousands of cancer-related lawsuits -FundGuru
Missouri House backs legal shield for weedkiller maker facing thousands of cancer-related lawsuits
View
Date:2025-04-13 07:40:01
JEFFERSON CITY, Mo. (AP) — The manufacturer of a popular weedkiller won support Wednesday from the Missouri House for a proposal that could shield it from costly lawsuits alleging it failed to warn customers its product could cause cancer.
The House vote marked an important but incremental victory for chemical giant Bayer, which acquired an avalanche of legal claims involving the weedkiller Roundup when it bought the product’s original St. Louis-area-based producer, Monsanto.
The legislation now heads to the Missouri Senate with several weeks remaining in the annual legislative session. Bayer pursued similar legislation this year in Idaho and Iowa, where it has mining and manufacturing facilities, but it fell short in both states.
Bayer disputes claims that Roundup’s key ingredient, glyphosate, causes a cancer called non-Hodgkin’s lymphoma. But it has set aside $16 billion and already paid about $10 billion of that amount to resolve some of the tens of thousands of legal claims against it.
Though some studies associate glyphosate with cancer, the U.S. Environmental Protection Agency has said it is not likely to be carcinogenic to humans when used as directed.
The Missouri legislation says that federally approved pesticide labeling “shall be sufficient to satisfy any requirement for a warning label regarding cancer” — effectively thwarting failure-to-warn allegations in future lawsuits.
“We are grateful that members of the Missouri House have supported farmers and science over the litigation industry,” Bayer said in a statement Wednesday.
A coalition that includes Bayer has run ads on radio stations, newspapers and billboards supporting the legislation.
Farmers overwhelmingly rely on Roundup, which was introduced 50 years ago as a more efficient way to control weeds and reduce tilling and soil erosion. For crops including corn, soybeans and cotton, it’s designed to work with genetically modified seeds that resist Roundup’s deadly effect.
More than a dozen majority party Republicans joined Democrats in voting against the legislation as it passed the House on a 91-57 vote. Some Democrats made personal pleas to vote no.
“If you vote for this bill, you are voting for cancer — and it will hurt my feelings, and I will not smile at you on the elevator,” said state Rep. LaDonna Appelbaum, who is undergoing treatment for cancer.
Supporters said it was important to protect Bayer, whose North American crop science division is based in the St. Louis area, from lawsuits that could jeopardized the availability of Roundup. They cited concerns that Bayer eventually could pull Roundup from the U.S. market, leaving farmers dependent on alternative chemicals from China.
“This bill isn’t about cancer, it’s really about the process of what’s taken place within the courts,” said Republican state Rep. Mike Haffner, chair of the House Agriculture Policy Committee.
veryGood! (19396)
Related
- See you latte: Starbucks plans to cut 30% of its menu
- Rainn Wilson, Jenna Fischer, more 'Office' stars reunite in ad skit about pillow company
- Jessica Simpson Reveals How Becoming a Mom Gave Her Body Confidence
- Rainn Wilson, Jenna Fischer, more 'Office' stars reunite in ad skit about pillow company
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Triathlon
- We Promise Checking Out Victoria Beckham's Style Evolution Is What You Really, Really Want
- Jessica Simpson Reveals How Becoming a Mom Gave Her Body Confidence
- Jessica Simpson Reveals How Becoming a Mom Gave Her Body Confidence
- Tom Holland's New Venture Revealed
- Hundreds of African immigrants in New York City rally for more protections
Ranking
- 'Vanderpump Rules' star DJ James Kennedy arrested on domestic violence charges
- Four people shot -- one fatally -- in the Bronx by shooters on scooters
- Stock market today: Asian benchmarks are mixed while US seems committed to current rates
- South Carolina making progress to get more women in General Assembly and leadership roles
- McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
- Hulu's 'Under the Bridge' will make you wonder where your children are
- Federal judge denies request from a lonely El Chapo for phone calls, visits with daughters and wife
- Catholic officials in Brooklyn agree to an independent oversight of clergy sex abuse allegations
Recommendation
McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
Chiefs' Patrick Mahomes lands on cover for Time 100 most influential people of 2024
Lakers lock up No. 7 seed with play-in tournament win over Pelicans, setting up rematch with Nuggets
How Ukraine aid views are shaped by Cold War memories, partisanship…and Donald Trump — CBS News poll
Trump suggestion that Egypt, Jordan absorb Palestinians from Gaza draws rejections, confusion
Some families left in limbo after Idaho's ban on gender-affirming care for minors allowed to take effect
Ford recalls over 450,000 vehicles in US for issue that could affect battery, NHTSA says
Trump Media launching Truth Social streaming service, where it says creators won't be cancelled